DE69006046D1 - Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen. - Google Patents

Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen.

Info

Publication number
DE69006046D1
DE69006046D1 DE90101834T DE69006046T DE69006046D1 DE 69006046 D1 DE69006046 D1 DE 69006046D1 DE 90101834 T DE90101834 T DE 90101834T DE 69006046 T DE69006046 T DE 69006046T DE 69006046 D1 DE69006046 D1 DE 69006046D1
Authority
DE
Germany
Prior art keywords
sialic acid
substances containing
bacterial toxins
neutralize bacterial
binding sialic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE90101834T
Other languages
English (en)
Other versions
DE69006046T2 (de
Inventor
Hiroko Isoda
Yoshihiro Kawasaki
Morimasa Tanimoto
Shunichi Dosako
Tadashi Idota
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DE69006046D1 publication Critical patent/DE69006046D1/de
Publication of DE69006046T2 publication Critical patent/DE69006046T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
DE69006046T 1989-02-07 1990-01-30 Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen. Expired - Fee Related DE69006046T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1027823A JP2805490B2 (ja) 1989-02-07 1989-02-07 細菌毒素中和剤

Publications (2)

Publication Number Publication Date
DE69006046D1 true DE69006046D1 (de) 1994-03-03
DE69006046T2 DE69006046T2 (de) 1994-08-04

Family

ID=12231672

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69006046T Expired - Fee Related DE69006046T2 (de) 1989-02-07 1990-01-30 Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen.

Country Status (4)

Country Link
US (1) US5330975A (de)
EP (1) EP0385118B1 (de)
JP (1) JP2805490B2 (de)
DE (1) DE69006046T2 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4008033A1 (de) * 1990-03-14 1991-09-19 Nitsche Dietrich Verwendung von lactoferrin zur bekaempfung der toxischen wirkung des endotoxins
US5240909B1 (en) * 1990-03-14 1998-01-20 Dietrich Nitsche Use of lactoferrin for treatment of toxic effects of endotoxins
EP0931097B1 (de) * 1996-10-10 2005-09-14 Neose Technologies, Inc. Reinigung von kohlenhydraten mittels umkehrosmose und nanofiltration
US6323008B1 (en) 1997-08-14 2001-11-27 Neose Technologies, Inc. Methods for producing sialyloligosaccharides in a dairy source
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
JP4717175B2 (ja) * 2000-01-27 2011-07-06 雪印乳業株式会社 シアロムチンの分泌促進剤
CA2399063C (en) * 2000-02-04 2014-01-28 Societe Des Produits Nestle S.A. A method for maintaining or improving the synthesis of mucins
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
US6482396B1 (en) * 2001-05-15 2002-11-19 Campina Melkunie B.V. Methods for treating or preventing diseases of the oral cavity
US20030166866A1 (en) * 2002-01-28 2003-09-04 Land O' Lakes, Inc. Method of processing a proteinaceous material to recover K-casein macropeptide and polymers of a-lactalbumin and B-lactoglobulin
US7951410B2 (en) * 2003-04-14 2011-05-31 Mead Johnson Nutrition Company Enteral compositions containing caseinoglycomacropeptide having an enhanced concentration of sialic acid
CA2542448A1 (en) † 2003-10-13 2005-05-06 Nestec S.A. Moderating the effect of endotoxins
BRPI0415388A (pt) * 2003-10-13 2006-12-12 Nestec Sa moderação do efeito das endotoxinas
US20100119412A1 (en) * 2008-11-07 2010-05-13 Aries Associates, Inc. Novel Chemistries, Solutions, and Dispersal Systems for Decontamination of Chemical and Biological Systems
US20100179368A1 (en) * 2008-11-07 2010-07-15 Aries Associates, Inc. Novel Chemistries, Solutions, and Dispersal Systems for Decontamination of Chemical and Biological Systems
US9220751B2 (en) 2010-04-21 2015-12-29 Mileutis Ltd. Casein peptide for use in the treatment of uterine infections

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US126961A (en) * 1872-05-21 Improvement in compounds for the cure of cholera in hogs
FR2296428A1 (fr) * 1975-01-03 1976-07-30 Baignes Ste Radegonde Laiterie Composition de proteines a usage dietetique et therapeutique chez le nourrisson, l'enfant et l'adulte
JPS5572819A (en) 1978-11-29 1980-06-02 Hitachi Ltd Unfilled flow meter
DE3070189D1 (en) * 1979-03-16 1985-03-28 Merieux Inst Medicament, particularly for the treatment of cholera, and pharmaceutical compositions containing it
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
AU561067B2 (en) * 1982-03-22 1987-04-30 Biocarb Ab Anti-bacterial composition containing an oligosaccharide
JPS59918A (ja) 1982-06-25 1984-01-06 住友軽金属工業株式会社 電解コンデンサ用高純度アルミニウム箔およびその製造法
JPS59181497A (ja) 1983-03-31 1984-10-15 東芝ライテック株式会社 けい光ランプ点灯装置
JPS59184197A (ja) 1983-04-01 1984-10-19 Snow Brand Milk Prod Co Ltd シアル酸結合オリゴ糖の調製法
JPS6112695A (ja) 1984-06-28 1986-01-21 Rikagaku Kenkyusho シアル酸誘導体
LU85479A1 (fr) * 1984-07-25 1986-02-12 Oleofina Sa Compositions antibacteriennes de nourriture pour animaux et procede pour les preparer
JPS61145200A (ja) 1984-12-19 1986-07-02 Snow Brand Milk Prod Co Ltd ウシラクトフェリンの分離精製法
JPH0768135B2 (ja) * 1985-03-29 1995-07-26 株式会社ヤクルト本社 ボツリヌス毒素の中和剤
JP2631470B2 (ja) * 1987-05-15 1997-07-16 雪印乳業株式会社 感染防御剤
JP2622686B2 (ja) 1987-05-15 1997-06-18 雪印乳業株式会社 ｋ−カゼイングリコマクロペプチドの製造法
JP2673828B2 (ja) * 1989-04-19 1997-11-05 雪印乳業株式会社 κ―カゼイングリコマクロペプチドの製造法

Also Published As

Publication number Publication date
DE69006046T2 (de) 1994-08-04
EP0385118A3 (de) 1991-07-31
EP0385118B1 (de) 1994-01-19
JP2805490B2 (ja) 1998-09-30
EP0385118A2 (de) 1990-09-05
US5330975A (en) 1994-07-19
JPH02207089A (ja) 1990-08-16

Similar Documents

Publication Publication Date Title
DE69006046D1 (de) Verwendung von Sialinsäure enthaltenden oder bindenden Stoffen zur Neutralisierung von bakteriellen Toxinen.
AU578612B2 (en) Adhesive composition resistant to biological fluids
DE3584013D1 (de) Zubereitung zur behandlung von psoriasis.
AU4159185A (en) Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelets with vessel walls
ATE14936T1 (de) Verwendung von reagenzstreifen zur herstellung von reagenzloesungen.
DE3586159T2 (de) Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
ATE124992T1 (de) Methode zur züchtung von bakterien.
DE68909179D1 (de) Verschlusselement zur Kontrolle von Ileokolostomie.
DE3878627T2 (de) Zusammensetzung zur oberflaechenbehandlung von kautschuk.
PT78374A (en) Biological wastewater treating system cross-reference to parent application
DE69015566D1 (de) Umkehrbare Modifikation von biologischen Verbindungen zur Ermittlung, Trennung und Reinigung davon.
AT384825B (de) Vorgefertigter naehrbodentraeger zur qualitativen und quantitativen bestimmung von mikroorganismen
DE3772464D1 (de) Verwendung von zinksalz und b6-vitamin-mischungen zur begrenzung des alopezie- und/oder seborrhoeprozesses.
DE3584926D1 (de) Behandlung von oedemen mit hohem proteingehalt durch direktes aufbringen von benzopyronen.
DE3877293T2 (de) Fluessige zusammensetzung zur impraegnierung von glasfasern.
AU4602785A (en) Verfahren zur bestimmung des zeta-potentials von feststoffen
DE3781667D1 (de) Verwendung von 24,25-dihydroxycholecalciferol zur verhuetung des knochenalterns.
DE68925918D1 (de) Methode zur Reinigung von Antithrombin-III und Antithrombin-III-Zusammensetzung enthaltend dieses Antithrombin-III
DE3580007D1 (de) Verfahren zur reinigung von rohem beta-phenylethylalkohol.
AT388748B (de) Vorrichtung zur bestimmung von mikroorganismen
DE3584719D1 (de) Verwendung von nisin zur verhinderung des verderbens alkoholischer getraenke.
DE59601668D1 (de) Verwendung von natursauren smektiten zur entfernung von olefinen aus aromaten oder aromatengemischen
BR8705815A (pt) Processo para controlar o crescimento de microorganismos e processo para controlar doencas ou crescimento de microorganismos indesejados
DE3583337D1 (de) Zusammensetzung zur behandlung von haemorroiden.
DE3751059T2 (de) Verwendung von Corticosteroide zur Verringerung von postoperativen Schmerzen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee